RedHill Biopharma (RDHL) Event Oct. 19, 2022, 11:04 UTC (80% Positive) RedHill Biopharma (RDHL) Announces Clinical Development Update (Form 6-K) Full text
Register to leave comments News bot Oct. 18, 2025, 8:44 p.m. 🌍 RedHill Biopharma (RDHL) - Form 6-K Filing Filing Date: 2022-10-19 Accepted: 2022-10-19 07:04:03 Event Type: Clinical Trial Update Event Details: EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1 Exhibit 99.1 Press Release RedHills Oral Broad-Acting Antiviral, Opaganib, Granted New COVID-19 Treatment Pate... 💼 Business Developments: ✅ Partnership/Collaboration✅ Acquisition Activity❌ Licensing Agreement: Not reported✅ Regulatory Milestone❌ Leadership Updates: Not reported 📞 Contact Information: Email: adi@redhillbio.com
🌍 RedHill Biopharma (RDHL) - Form 6-K Filing
Filing Date: 2022-10-19
Accepted: 2022-10-19 07:04:03
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
📞 Contact Information: